Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 16/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL871335 | 1.00 | PDE4B (0.34) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL872271 | 0.90 | PDE4B (0.42) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL872270 | 0.90 | PDE4B (0.42) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL16087446 | 0.88 | PDE4B (0.36) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL870162 | 0.88 | PDE4B (0.36) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL870163 | 0.88 | PDE4B (0.36) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL3022338 | 0.87 | PDE4B (0.42) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL3022331 | 0.87 | PDE4B (0.42) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL870531 | 0.87 | PDE4B (0.38) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 | |
| SCHEMBL870532 | 0.87 | PDE4B (0.38) | PDE4BCYP3A4CYP2C9CYP2C19KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077801-A1 | Chemical Compounds 637 | ALCON RESEARCH, LTD. | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077801-A1 | Chemical Compounds 637 | PDE4A, PDE4B, PDE3B | PDE4B 2/4885CYP3A4 116/4885CYP2C9 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.